Clinical Trials Directory

Trials / Conditions / Anticoagulants

Anticoagulants

42 registered clinical trials studyying Anticoagulants4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingCatheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
NCT07441382
Guangdong Provincial People's HospitalN/A
Not Yet RecruitingA Study of Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascul
NCT06729034
Oslo University HospitalPhase 2
CompletedVariability in Micro-CT Imaging Results to Quantify Dialyzer Clotting
NCT06140563
University Hospital, GhentN/A
UnknownApplication of "I-Anticoagulation"in Patients With Atrial Fibrillation
NCT06137794
RenJi HospitalN/A
UnknownSelf-care and Self-efficacy Scale in Oral Anticoagulation Therapy
NCT05820854
IRCCS Policlinico S. Donato
CompletedDialysis Performance of the FX CorAL Membrane
NCT06203795
University Hospital, GhentN/A
RecruitingShared Decision for Drug Interactions in Oral Anticoagulation
NCT06401863
University of UtahN/A
UnknownAntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
NCT04796714
University Hospital, BordeauxPhase 4
CompletedBivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
NCT05334654
University Magna GraeciaN/A
UnknownAssociation of Obesity and Cardiovascular Outcomes in Atrial Fibrillation
NCT05645913
Ajou University School of Medicine
UnknownComparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoin
NCT04977076
Zuyderland Medisch CentrumN/A
WithdrawnHYDROxychloroquine in Syndrome Primary AntiPhospholipid
NCT04275778
Assistance Publique - Hôpitaux de ParisPhase 2
CompletedMIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Cl
NCT05065502
VA Office of Research and DevelopmentN/A
CompletedOptimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer
NCT04724460
Takeshi MorimotoPhase 4
CompletedCoordination of Oral Anticoagulant Care at Hospital Discharge
NCT02777047
St. Joseph's Healthcare HamiltonN/A
CompletedEffectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients Wi
NCT04681482
Pfizer
RecruitingAnticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH
NCT04861103
University of California, IrvinePhase 4
CompletedClopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb Revascularization
NCT04168398
Mansoura UniversityPhase 1 / Phase 2
UnknownSafety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxyg
NCT03965208
Legacy Health SystemPhase 4
UnknownEpidemiological Description of Health Determinants in Italian Anticoagulated Population
NCT05710562
IRCCS Policlinico S. Donato
UnknownEfficacy, Safety and Pharmacokinetics of Tinzaparin During Slow Low Efficient Daily Dialysis in Intensive Care
NCT03614741
Tampere University HospitalPhase 4
UnknownEvaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patient
NCT03666962
Cui Yimin
UnknownPharmacists' Intervention in Patients Using Novel Oral Anticoagulants:A Study on Behavioral Patterns
NCT03670446
Cui YiminN/A
TerminatedApixaban for Extended Anticoagulation (APIDULCIS)
NCT03678506
Arianna Anticoagulazione FoundationPhase 4
CompletedSupporting Use of AC Through Provider Profiling of Oral AC Therapy for AF
NCT03583008
University of Massachusetts, WorcesterN/A
CompletedStudy Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO
NCT03318393
University of Texas Southwestern Medical CenterPhase 4
UnknownManagement and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia
NCT03288441
Maastricht University Medical Center
UnknownClinical Decision Support Tool for Improving the Adequacy of Anticoagulant Therapy in Non-valvular Atrial Fibr
NCT03367325
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i GurinaN/A
UnknownRandomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy
NCT02594501
CeloNova BioSciences, Inc.N/A
CompletedEfficacy of a Health Belief Model Based Intervention for Anticoagulation Adherence
NCT03864900
National Taipei University of Nursing and Health SciencesN/A
CompletedInfluence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Advers
NCT02103101
Centre Hospitalier Universitaire de BesanconN/A
CompletedImproving Anticoagulation Control in VISN 1
NCT01653405
VA Office of Research and DevelopmentN/A
CompletedPharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or Mor
NCT02360943
Centre Hospitalier Universitaire de Saint Etienne
CompletedI.M. Sechenov First Moscow State Medical University (Sechenov University)
NCT05319340
I.M. Sechenov First Moscow State Medical UniversityN/A
CompletedUse of Public Health Surveillance Models in the French National Health System Database
NCT02904499
Centre Hospitalier Universitaire de la Réunion
TerminatedComparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Trea
NCT02128841
Insel Gruppe AG, University Hospital BernPhase 2
WithdrawnHeparin Versus no Heparin on Duration of Peripherally Inserted Central Catheter (PICC) Patency in Neonates
NCT00879957
The University of Texas Health Science Center at San AntonioN/A
CompletedQuality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy
NCT01033279
Montreal Heart InstituteN/A
CompletedWOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Cor
NCT00769938
R&D CardiologiePhase 4
CompletedStudy to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT
NCT00585182
University of UtahPhase 4
CompletedDaily Vitamin K in Patients on Warfarin With Unstable INRs
NCT00287313
University of North Carolina, Chapel HillN/A
CompletedInfluenza Vaccination and Oral Anticoagulant Therapy
NCT00222638
University Of PerugiaPhase 4